
Kayentis & RWS partnering for success
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and
“DCT is not the goal, just the means” webinar
Learning objectives:
Abstract:
Decentralized clinical trials (DCTs) seek to offer many advantages to clinical trials. They are necessary to decrease patient burden and increase access to clinical trials. Different virtual solutions, complementary to eCOA, have proven their efficacy to make participation in clinical trials less prohibitive and improve participant retention. And patients and sites are ready for decentralized/hybrid clinical trials.
However, there are many challenges, that impose key considerations for the implementation of successful Decentralized Clinical Trials (DCTs): How do we avoid data loss and lack of patient compliance when patients do not come to site? How do we respond to regulatory constraints and compensate the lack of supervision to ensure data quality? How do we tackle technological challenges, and ensure site adoption?
Speakers:
Estelle Haenel
Medical Director @Kayentis
Grace Gartel
Clinical Operations Project Manager @Kayentis
Kayentis (global provider of eCOA and DCT solutions) and RWS (language service provider (LSP) and
Provide clinical trial participants with clear and simple information, anywhere, anytime thanks to the Kayentis
Using technology to add flexibility to clinical trials can support patients and sites – but
Many of the challenges of clinical trials are well known, but oncology trials differ from
Patients taking part in clinical trials need clear and simple information – this is what
Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized
Last update : 18 June 2022